394 related articles for article (PubMed ID: 10379686)
1. Development of resistance and cross-resistance in Pseudomonas aeruginosa exposed to subinhibitory antibiotic concentrations.
Wu YL; Scott EM; Po AL; Tariq VN
APMIS; 1999 Jun; 107(6):585-92. PubMed ID: 10379686
[TBL] [Abstract][Full Text] [Related]
2. Development of antibiotic resistance in Pseudomonas aeruginosa during two decades of antipseudomonal treatment at the Danish CF Center.
Ciofu O; Giwercman B; Pedersen SS; Høiby N
APMIS; 1994 Sep; 102(9):674-80. PubMed ID: 7946270
[TBL] [Abstract][Full Text] [Related]
3. [Synergistic activity between ticarcillin, azlocillin, cefsulodin, ceftazidime and tobramycin or amikacin against Pseudomonas aeruginosa (author's transl)].
Petit JC; Richard G; Burghoffer B; Daguet GL
Pathol Biol (Paris); 1982 Jun; 30(6):426-31. PubMed ID: 6810286
[TBL] [Abstract][Full Text] [Related]
4. [Influence of the inoculum effect on the MIC and MBC of 5 beta-lactams against Pseudomonas aeruginosa].
Croize J; Le Noc P; Robert J
Pathol Biol (Paris); 1984 May; 32(5):412-4. PubMed ID: 6429613
[TBL] [Abstract][Full Text] [Related]
5. Antibiotic treatment of chronic Pseudomonas aeruginosa infection in cystic fibrosis patients.
Møller NE; Høiby N
Scand J Infect Dis Suppl; 1981; 29():87-91. PubMed ID: 6458884
[TBL] [Abstract][Full Text] [Related]
6. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
Ciofu O
APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154
[TBL] [Abstract][Full Text] [Related]
7. [Pseudomonas aeruginosa: acquired in vitro resistance to beta-lactams].
Thabaut A; Meyran M
Pathol Biol (Paris); 1983 May; 31(5):387-91. PubMed ID: 6413939
[TBL] [Abstract][Full Text] [Related]
8. [Comparative activity of ticarcillin-clavulanic acid and various beta-lactams against Pseudomonas maltophilia].
Monteil H; Jehl F
Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):805-8. PubMed ID: 3309818
[TBL] [Abstract][Full Text] [Related]
9. Previous ciprofloxacin exposure is associated with resistance to beta-lactam antibiotics in subsequent Pseudomonas aeruginosa bacteremic isolates.
López-Dupla M; Martínez JA; Vidal F; Almela M; Soriano A; Marco F; López J; Olona M; Mensa J
Am J Infect Control; 2009 Nov; 37(9):753-8. PubMed ID: 19487049
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial use and Pseudomonas aeruginosa susceptibility profile in a cystic fibrosis centre.
Manno G; Cruciani M; Romano L; Scapolan S; Mentasti M; Lorini R; Minicucci L
Int J Antimicrob Agents; 2005 Mar; 25(3):193-7. PubMed ID: 15737511
[TBL] [Abstract][Full Text] [Related]
11. [Surveillance of Pseudomonas aeruginosa sensitivity to antibiotics in France and distribution of beta-lactam resistance mechanisms: 1998 GERPB study].
Cavallo JD; Leblanc F; Fabre R
Pathol Biol (Paris); 2000 Jun; 48(5):472-7. PubMed ID: 10949844
[TBL] [Abstract][Full Text] [Related]
12. Susceptibility of Pseudomonas aeruginosa to beta-lactam antibiotics.
Philippon A
Chemioterapia; 1985 Dec; 4(6):424-8. PubMed ID: 3938346
[TBL] [Abstract][Full Text] [Related]
13. Ability of azlocillin and tobramycin in combination to delay or prevent resistance development in Pseudomonas aeruginosa.
Wu YL; Scott EM; Po AL; Tariq VN
J Antimicrob Chemother; 1999 Sep; 44(3):389-92. PubMed ID: 10511408
[TBL] [Abstract][Full Text] [Related]
14. Susceptibility patterns and cross-resistance of antibiotics against Pseudomonas aeruginosa isolated from burn patients in the South of Iran.
Japoni A; Alborzi A; Kalani M; Nasiri J; Hayati M; Farshad S
Burns; 2006 May; 32(3):343-7. PubMed ID: 16527415
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of piperacillin, ticarcillin, mezlocillin, ticarcillin-clavulanic acid, aztreonam, ceftazidime, azlocillin, cefoperazone, and thienamycin against Pseudomonas aeruginosa.
Greenberg RN; Bollinger MR; Alivisatos MR
Clin Ther; 1986; 8(6):655-7. PubMed ID: 3098426
[TBL] [Abstract][Full Text] [Related]
16. [Susceptibility of Pseudomonas aeruginosa to aztreonam in comparison to other pseudomonas-active beta-lactam antibiotics and gentamicin].
Wundt W; Lange KP; Baumgärtner M
Arzneimittelforschung; 1985; 35(8):1322-5. PubMed ID: 3935123
[TBL] [Abstract][Full Text] [Related]
17. [Sensitivity of Pseudomonas aeruginosa to beta-lactam antibiotics and effects of beta-lactamases].
Avril JL; Cayla AM; Guist'hau O; Moillo-Batt A
Pathol Biol (Paris); 1983 Jun; 31(6):471-5. PubMed ID: 6410345
[TBL] [Abstract][Full Text] [Related]
18. [Sensitivity of Pseudomonas aeruginosa to beta-lactam antibiotics. Apropos of 338 strains isolated at the Regional Hospital Center at Nantes in 1984].
Reynaud AE; Coude du Foresto B; Espaze EP; Courtieu AL
Pathol Biol (Paris); 1987 Sep; 35(7):1023-6. PubMed ID: 3118324
[TBL] [Abstract][Full Text] [Related]
19. [Pseudomonas aeruginosa: bactericidal activity on various beta-lactam resistance phenotypes of 8 antibiotics and 7 combinations].
Dubrous P; Cavallo JD; Hernandez E; Nordmann P; Fabre R
Pathol Biol (Paris); 1997 May; 45(5):433-7. PubMed ID: 9296099
[TBL] [Abstract][Full Text] [Related]
20. [Evolution of antimicrobial resistance against Pseudomonas aeruginosa in a French university hospital between 2002 and 2006].
Minchella A; Molinari L; Alonso S; Bouziges N; Sotto A; Lavigne JP
Pathol Biol (Paris); 2010 Feb; 58(1):1-6. PubMed ID: 19875241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
